Healthy Living/WellnessFDA Panel Not Persuaded By Effectiveness Of BioMarin Duchenne Muscular Dystrophy Drug U.S. Food and Drug Administration advisers were not convinced of BioMarin Muscular Dystrophy drug's efficacy based on clinical trials. Drisapersen, fell short in proving its effectiveness in patients suffering from Duchenne muscular dystrophy.by Angela Laguipo
Healthy Living/WellnessFDA Seeks Public Comment On Meaning Of Word 'Natural' On Food Labelsby Katherine Derla
Healthy Living/WellnessFDA Finds Quality Assurance Process Flaws At Theranos, Calls Nanotainer Uncleared Medical Deviceby Katherine Derla
ScienceGenetic Testing Company 23andMe Becomes First Direct-To-Consumer Service Approved By FDAby J.E. Reich
Healthy Living/WellnessMedline Industries Recalls Mislabeled Acetaminophen: Affected Products Could Lead To Liver Failureby Katrina Pascual
Healthy Living/WellnessSprout's Female Viagra Goes On Sale But It's Not For Everyoneby Christian de Looper
Healthy Living/WellnessBlood Test Startup Theranos Faces Scrutiny: FDA Says Nanotainer An 'Unapproved Medical Device'by Katherine Derla
Healthy Living/WellnessLamar Odom Collapse Linked To Herbal Viagra Pills: What To Know About This Sexual Enhancement Supplementby Katrina Pascual
Healthy Living/WellnessCollegium Pharmaceutical Says FDA Review Of Opioid Painkiller To Be Delayedby Ted Ranosa
Healthy Living/WellnessWhole Foods Recalls Papillon Organic Roquefort Cheese Due To Listeria Riskby Julienne Roman
South Korea's ICT Exports Hit All-Time Growth Rate of 125.9% in April, Driven by AI Server Chip Demand